JESSICA FAY: Open Payments
NPI 1477681534 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 56 payments from 23 companies in 2025. Trend: 2023 $1,001 · 2024 $805 · 2025 $1,443
Food & beverage: $1,365Education: $78
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $400 |
| Janssen Biotech, Inc. | 6 | $181 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Exelixis Inc. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| PharmaEssentia USA Corporation | 2 | $56 |
| TAIHO ONCOLOGY, INC. | 2 | $56 |
| TerSera Therapeutics LLC | 2 | $49 |
| Incyte Corporation | 2 | $45 |
| BeOne Medicines USA, Inc. | 2 | $40 |
Products named: KEYTRUDA, WELIREG, RYBREVANT, CABOMETYX, CALQUENCE, Nubeqa, ERLEADA, BESREMI.
Industry payments across TN — which companies pay providers there.
